Background: The proportion of intensive care unit (ICU) admissions in children that have and have not been directly caused by SARS-CoV-2 remains unclear. The aim of the study is to analyse a cohort of children admitted to the ICU with SARS-CoV-2 and determine whether the infection was the primary cause of their hospitalisation, a significant contributor, a suspected accomplice, or an incidental finding. Methods: This was a retrospective observational study of all the children admitted to the ICU with SARS-CoV-2 from March 2020 to February 2022 from the South Moravia region. The aim of the study was to assess whether the hospitalisation was likely to be directly caused by the virus (i.e., patients with acute COVID-19; the COVID group), whether the virus was a significant contributor to the hospitalisation (i.e., patients with multisystem inflammatory syndrome in children due to COVID-19; the MIS-C group), whether it may have contributed to the worsening of their underlying disease (the WORSENING group), or whether it was an incidental finding very likely unrelated to hospitalisation where SARS-CoV-2 positivity merely placed patients in the COVID-19 unit (the ISOLATION group). The groups were compared using a series of secondary outcomes. Results: The study population represented 150 paediatric ICU cases (age 8.6; IQR 3.5−13.3 years), with 66.7% being male. The COVID group represented 32.7% of cases (49/150); MIS-C, 30% (45/150); WORSENING, 14.7% (22/150); and ISOLATION, 22.7% (34/150). The median length of hospitalisation was found for the MIS-C group (11 days; 9 days in the ICU), the COVID group (6 days; five days in the ICU), WORSENING group (4.5 days; 4.5 days in the ICU) and the ISOLATION group (5.5 days; 3.5 days in the ICU), where the difference was significant (p < 0.001). Asymptomatic and mild cases were most common in the WORSENING (36.4% and 63.6%) and ISOLATION (52.9% and 44.1%) groups. Severe and critical cases were only present in the COVID (6.1% and 12.2%) and MIS-C (4.4% and 11.1%) groups; the severity difference was significant (p < 0.001). The groups did not differ significantly in the proportion of complete recovery and short- and long-term sequelae (p = 0.09). Conclusions: Patients with acute COVID-19 accounted for one-third of all ICU admissions, patients with MIS-C accounted for approximately another third, patients with worsening underlying disease accounted for 15%, and patients with incidental findings of SARS-CoV-2 positivity accounted for one-fifth of ICU admissions. A more significant disease was seen with acute COVID-19 and MIS-C.

Department of Paediatric Anaesthesiology and Intensive Care Medicine University Hospital Brno Černopolní 9 61300 Brno Czech Republic

Department of Pediatric Infectious Diseases University Hospital Brno Černopolní 22a 61300 Brno Czech Republic

Department of Pediatric Neurology University Hospital Brno Černopolní 9 61300 Brno Czech Republic

Department of Pediatrics University Hospital Brno Černopolní 9 61300 Brno Czech Republic

Department of Simulation Medicine Faculty of Medicine Masaryk University Kamenice 5 62500 Brno Czech Republic

European Reference Network on Rare Respiratory Diseases Centre University Hospital Brno Jihlavská 20 62500 Brno Czech Republic

Faculty of Medicine Masaryk University Kamenice 5 62500 Brno Czech Republic

Zobrazit více v PubMed

Zimmermann P., Pittet L.F., Finn A., Pollard A.J., Curtis N. Should Children Be Vaccinated against COVID-19? Arch. Dis. Child. 2022;107:e1–e8. doi: 10.1136/archdischild-2021-323040. PubMed DOI

Delahoy M.J. Hospitalizations Associated with COVID-19 Among Children and Adolescents—COVID-NET, 14 States, March 1, 2020–August 14, 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1255. doi: 10.15585/mmwr.mm7036e2. PubMed DOI PMC

Marks K.J., Whitaker M., Anglin O., Milucky J., Patel K., Pham H., Chai S.J., Kirley P.D., Armistead I., McLafferty S., et al. Hospitalisations of Children and Adolescents with Laboratory-Confirmed COVID-19—COVID-NET, 14 States, July 2021–January 2022. MMWR Morb. Mortal. Wkly. Rep. 2022;71:271–278. doi: 10.15585/mmwr.mm7107e4. PubMed DOI PMC

Swann O.V., Holden K.A., Turtle L., Pollock L., Fairfield C.J., Drake T.M., Seth S., Egan C., Hardwick H.E., Halpin S., et al. Clinical Characteristics of Children and Young People Admitted to Hospital with COVID-19 in United Kingdom: Prospective Multicentre Observational Cohort Study. BMJ. 2020;370:m3249. doi: 10.1136/bmj.m3249. PubMed DOI PMC

Kim L., Whitaker M., O’Halloran A., Kambhampati A., Chai S.J., Reingold A., Armistead I., Kawasaki B., Meek J., Yousey-Hindes K., et al. Hospitalisation Rates and Characteristics of Children Aged < 18 Years Hospitalised with Laboratory-Confirmed COVID-19—COVID-NET, 14 States, March 1–July 25, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1081–1088. doi: 10.15585/mmwr.mm6932e3. PubMed DOI PMC

Irfan O., Muttalib F., Tang K., Jiang L., Lassi Z.S., Bhutta Z. Clinical Characteristics, Treatment and Outcomes of Paediatric COVID-19: A Systematic Review and Meta-Analysis. Arch. Dis. Child. 2021;106:440–448. doi: 10.1136/archdischild-2020-321385. PubMed DOI PMC

Feldstein L.R., Tenforde M.W., Friedman K.G., Newhams M., Rose E.B., Dapul H., Soma V.L., Maddux A.B., Mourani P.M., Bowens C., et al. Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19. JAMA. 2021;325:1074. doi: 10.1001/jama.2021.2091. PubMed DOI PMC

HAN Archive-00432|Health Alert Network (HAN) [(accessed on 30 October 2022)]; Available online: https://emergency.cdc.gov/han/2020/han00432.asp.

Octavius G.S., Wijaya J.H., Tan A.O., Muljono M.P., Chandra S., Juliansen A. Autopsy Findings of Pediatric COVID-19: A Systematic Review. Egypt. J. Forensic Sci. 2022;12:32. doi: 10.1186/s41935-022-00288-0. PubMed DOI PMC

Klučka J., Klabusayová E., Kratochvíl M., Musilová T., Vafek V., Skříšovská T., Kosinová M., Havránková P., Štourač P. Critically Ill Pediatric Patient and SARS-CoV-2 Infection. Children. 2022;9:538. doi: 10.3390/children9040538. PubMed DOI PMC

Shekerdemian L.S., Mahmood N.R., Wolfe K.K., Riggs B.J., Ross C.E., McKiernan C.A., Heidemann S.M., Kleinman L.C., Sen A.I., Hall M.W., et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. JAMA Pediatr. 2020;174:868. doi: 10.1001/jamapediatrics.2020.1948. PubMed DOI PMC

Woodruff R.C., Campbell A.P., Taylor C.A., Chai S.J., Kawasaki B., Meek J., Anderson E.J., Weigel A., Monroe M.L., Reeg L., et al. Risk Factors for Severe COVID-19 in Children. Pediatrics. 2022;149:e2021053418. doi: 10.1542/peds.2021-053418. PubMed DOI PMC

Bixler D., Miller A.D., Mattison C.P., Taylor B., Komatsu K., Peterson Pompa X., Moon S., Karmarkar E., Liu C.Y., Openshaw J.J., et al. SARS-CoV-2–Associated Deaths among Persons Aged <21 Years—United States, February 12–July 31, 2020. MMWR Morb. Mortal. Wkly. Rep. 2020;69:1324–1329. doi: 10.15585/mmwr.mm6937e4. PubMed DOI

Jiang L., Tang K., Levin M., Irfan O., Morris S.K., Wilson K., Klein J.D., Bhutta Z.A. COVID-19 and Multisystem Inflammatory Syndrome in Children and Adolescents. Lancet Infect. Dis. 2020;20:e276–e288. doi: 10.1016/S1473-3099(20)30651-4. PubMed DOI PMC

Götzinger F., Santiago-García B., Noguera-Julián A., Lanaspa M., Lancella L., Calò Carducci F.I., Gabrovska N., Velizarova S., Prunk P., Osterman V., et al. COVID-19 in Children and Adolescents in Europe: A Multinational, Multicentre Cohort Study. Lancet Child Adolesc. Health. 2020;4:653–661. doi: 10.1016/S2352-4642(20)30177-2. PubMed DOI PMC

Shi D.S., Whitaker M., Marks K.J., Anglin O., Milucky J., Patel K., Pham H., Chai S.J., Kawasaki B., Meek J., et al. Hospitalisations of Children Aged 5–11 Years with Laboratory-Confirmed COVID-19—COVID-NET, 14 States, March 2020–February 2022. MMWR Morb. Mortal. Wkly. Rep. 2022;71:574–581. doi: 10.15585/mmwr.mm7116e1. PubMed DOI PMC

Feldstein L.R., Rose E.B., Horwitz S.M., Collins J.P., Newhams M.M., Son M.B.F., Newburger J.W., Kleinman L.C., Heidemann S.M., Martin A.A., et al. Multisystem Inflammatory Syndrome in U.S. Children and Adolescents. N. Engl. J. Med. 2020;383:334–346. doi: 10.1056/NEJMoa2021680. PubMed DOI PMC

De Filippo M., Magri P., Bossi G., Brambilla I., Castagnoli R., Mascolo A., Votto M., Licari A., Marseglia G.L. Clinical and Epidemiological Features of Pediatric Patients with COVID-19 in a Tertiary Pediatric Hospital. Acta Biomed. Atenei Parm. 2022;93:e2022039. doi: 10.23750/abm.v93iS3.13074. PubMed DOI PMC

Cloete J., Kruger A., Masha M., du Plessis N.M., Mawela D., Tshukudu M., Manyane T., Komane L., Venter M., Jassat W., et al. Paediatric Hospitalisations Due to COVID-19 during the First SARS-CoV-2 Omicron (B.1.1.529) Variant Wave in South Africa: A Multicentre Observational Study. Lancet Child Adolesc. Health. 2022;6:294–302. doi: 10.1016/S2352-4642(22)00027-X. PubMed DOI PMC

Whittaker R., Greve-Isdahl M., Bøås H., Suren P., Buanes E.A., Veneti L. COVID-19 Hospitalization Among Children <18 Years by Variant Wave in Norway. Pediatrics. 2022;150:e2022057564. doi: 10.1542/peds.2022-057564. PubMed DOI

Carlotti A.P.d.C.P., de Carvalho W.B., Johnston C., Rodriguez I.S., Delgado A.F. COVID-19 Diagnostic and Management Protocol for Pediatric Patients. Clinics. 2020;75:e1894. doi: 10.6061/clinics/2020/e1894. PubMed DOI PMC

Sobolewska-Pilarczyk M., Pokorska-Śpiewak M., Stachowiak A., Marczyńska M., Talarek E., Ołdakowska A., Kucharek I., Sybilski A., Mania A., Figlerowicz M., et al. COVID-19 Infections in Infants. Sci. Rep. 2022;12:7765. doi: 10.1038/s41598-022-11068-0. PubMed DOI PMC

Zimmermann P., Pittet L.F., Curtis N. How Common Is Long COVID in Children and Adolescents? Pediatr. Infect. Dis. J. 2021;40:e482–e487. doi: 10.1097/INF.0000000000003328. PubMed DOI PMC

Radtke T., Ulyte A., Puhan M.A., Kriemler S. Long-Term Symptoms After SARS-CoV-2 Infection in Children and Adolescents. JAMA. 2021;326:869. doi: 10.1001/jama.2021.11880. PubMed DOI PMC

Molteni E., Sudre C.H., Canas L.S., Bhopal S.S., Hughes R.C., Antonelli M., Murray B., Kläser K., Kerfoot E., Chen L., et al. Illness Duration and Symptom Profile in Symptomatic UK School-Aged Children Tested for SARS-CoV-2. Lancet Child Adolesc. Health. 2021;5:708–718. doi: 10.1016/S2352-4642(21)00198-X. PubMed DOI PMC

Capone C.A., Misra N., Ganigara M., Epstein S., Rajan S., Acharya S.S., Hayes D.A., Kearney M.B., Romano A., Friedman R.A., et al. Six Month Follow-up of Patients with Multi-System Inflammatory Syndrome in Children. Pediatrics. 2021;148:e2021050973. doi: 10.1542/peds.2021-050973. PubMed DOI

Octavius G.S., Tan R., Pratama T.A., Budiputri C.L., Meliani F., Heriyanto R.S., Muljadi R., Juliansen A. Cardiac Manifestations and Diagnostic Imaging in Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19: A Systematic Review. Med. J. Indones. 2022;31:20–37. doi: 10.13181/mji.oa.225754. DOI

Putri N.D., Prawira Y., Tartila T., Jasin M.R., Puspitasari H.A., Puspaningtyas N.W., Indawati W., Karyanti M.R., Setyanto D.B., Prayitno A., et al. Clinical Features of Multisystem Inflammatory Syndrome in Children Associated with COVID-19 in Indonesia. J. Trop. Pediatr. 2022;68:fmac025. doi: 10.1093/tropej/fmac025. PubMed DOI PMC

O’Loughlin L., Alvarez Toledo N., Budrie L., Waechter R., Rayner J. A Systematic Review of Severe Neurological Manifestations in Pediatric Patients with Coexisting SARS-CoV-2 Infection. Neurol. Int. 2021;13:410–427. doi: 10.3390/neurolint13030041. PubMed DOI PMC